Central and Eastern Sydney PHN has partnered with the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) to deliver an incentivised Quality Improvement program for General Practice.
Beyond the C will guide General Practices to undertake hepatitis C data-searching, review clinical files, and recall people for testing and treatment. Practices will have the support of the ASHM project team, Practice Nurse Advisors, and the Hub resources as well as support from the PHN.
Practices would undertake 6 months of Quality improvement and be eligible for $4000 payment over two installments.
Practices who use POLAR can access a tailor-made report to assist in identifying those with a Hepatitis C diagnosis, who might require treatments. CESPHN and ASHM can support practices through the process of prescribing treatment if this is not a familiar area, or referral where appropriate.
Practices who use PenCAT or other mechanisms to share data can have access to POLAR for use of the Hepatitis C report, for use in the Beyond the C program, but is it not a requirement for participation.
Please contact sexualhealth@cesphn.com.au to learn more or gain access to the POLAR Hep C tool, and/or the Beyond the C project.
Register your interest in Beyond the C and help eliminate hepatitis C by 2030:
Health Referral Forms
Immunisation Weekly Update: Immunisation Professional Development Conference Handbook influenza chapter updates · Increased measles risk in NSW · Education Immunisation Professional Development Conference Registrations are free and open now for Benchmarque’s 2026 Immunisation Professional Development Conference in Sydney. The one day in-person event will include sessions addressing vaccine hesitancy, travel…
Immunisation Weekly Update: Trivalent influenza vaccine formulation in 2026 RSV vaccination in pregnancy – Updated advice Influenza immunisation resources for 2026 New COVID vaccine variant well tolerated Education Trivalent influenza vaccine formulation in 2026 In 2026, the composition of influenza vaccines will transition from quadrivalent to trivalent formulations. This aligns…
2026 influenza vaccine advice for patients Influenza (the flu) is a common viral infection that affects people of all ages. While it may be a mild disease for some, it can also cause serious sickness and may even lead to hospitalisation, even in healthy people. Getting a flu vaccine every…
2026 influenza vaccine advice The Department of Health, Disability and Ageing have released several key materials relating to the 2026 influenza vaccination program. Program advice for health professionals The program advice provides key details regarding 2026 influenza vaccinations, including: Vaccination timing Vaccine strains Guidance for different population groups Eligibility for…
